Research & Reviews : Journal of Medical Science and Technology

ISSN: 2319-3417

Editors Overview

rrjomst maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Open Access
Special Issue
Topic

Breast cancer immunotherapy and targeted therapy

Abstract Submission Deadline : November 30, 2024

Manuscript Submission Deadline : December 25, 2024

Special Issue Description

Worldwide, breast cancer still ranks as one of the leading causes of cancer death. The numerous immunotherapeutic and targeted therapy approaches currently under investigation offer hope for a better prognosis for patients with breast cancer.These methods include using immunotherapeutic checkpoint inhibitors in approved clinical settings to treat metastatic triple-negative breast cancer that has PD-L1 expression, as well as BRCA-deficient breast malignancies with poly (ADP-ribose) polymerase (PARP) inhibitors. Although encouraging, these focused techniques have only had limited success, necessitating further improvements in patient classification and innovative drug/target combinations. We welcome papers on breast cancer that look at the many facets of immunotherapeutic and targeted therapy approaches. Original research articles and reviews are encouraged for this topic. Pre-clinical and clinical studies that look at the different facets of immunotherapeutic and targeted therapeutic strategies, as well as cutting-edge drug delivery techniques, may be included in—but are not limited to—research on breast cancer.

Keywords

Breast cancer, Immunotherapy, Immune checkpoint blockade, Targets, Inhibitors, Precision medicine, Cancer nanomedicine

Manuscript Submission information

Manuscripts should be submitted online via the manuscript Engine. Once you register on APID, click here to go to the submission form. Manuscripts can be submitted until the deadline.
All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the email address:[email protected] for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a Double-blind peer-review process. A guide for authors and other relevant information for the submission of manuscripts is available on the Instructions for Authors page.

Participating journals: